Vaccines Related News
CoronaVac COVID-19 vaccine safe for children as young as three
A clinical trial has proven that the CoronaVac COVID-19 vaccine is safe for children and adolescents aged between three to 17.
The CoronaVac vaccine, which...
Defence Therapeutics: Transforming drug delivery and improving treatment
Defence Therapeutics is continuously expanding on its portfolio of solutions to enhance drug delivery and improve treatment outcomes for patients with cancer and infectious...
Understanding COVID-19 and the vaccine cold chain
B Medical Systems discusses the importance of reliable, high quality bio-medical storage and the crucial impact of the vaccine cold chain.
Optimal cold chain infrastructures...
Defence Therapeutics Accutox exhibits potent anti-cancer properties
Defence Therapeutics Inc. has announced a major breakthrough advance in its pre-clinical research program on its AccuTOX molecules as potent anti-cancer agents.
The AccumTM technology...
Clinicians urged to spot Guillain-Barre syndrome after COVID-19 vaccines
Clinicians have urged for vigilance in looking for the rare neurological disorder Guillain-Barre syndrome in individuals following COVID-19 vaccination.
Clinicians in India and England have...
Intellectual property and vaccine equality in a pandemic
Akshaya Kumar, Director of Crisis Advocacy at Human Rights Watch, speaks to us about intellectual property and vaccine inequity.
In October 2020, representatives of India...
Improving communication and collaboration around vaccines
Alison Maassen and Alba Godfrey of EuroHealthNet explain the importance of the IMMUNION project in improving public knowledge and confidence around vaccines.
Vaccines are a...
Towards a cancer revolution with new targeted therapeutics
Defence Therapeutics Inc’s proprietary new platform offers a revolution in drug delivery.
Quebec-based biotechnology developer Defence Therapeutics Inc specialises in antibody-drug conjugates (ADCs), a novel...
Defence therapeutics vaccine against cancer makes progress
Defence Therapeutics has recently reported its first successes in the fight against cancer with a vaccine.
Defence Therapeutics is a Canadian scientific pioneer, uncovering enhanced...
Is vaccine hesitancy in Africa linked to institutional mistrust?
Dr Jean-François Maystadt, Professor of Economics at Université catholique de Louvain and Lancaster University, discusses institutional mistrust and vaccine hesitancy in Africa.
In a report...
Securing COVID-19 vaccine certificates with distributed ledger
Alex Fryer at Zebra Technologies discusses global vaccine certification systems combined with the use of distributed ledger technology to improve data security and prevent...
Study demonstrates long-lasting efficacy of COVID-19 vaccine programme
Researchers carrying out pre-clinical testing of a COVID-19 vaccine programme have discovered a high antibody response, lasting over 18 weeks.
Biotechnology company Defence Therapeutics Inc...
Mild myocarditis reported with COVID-19 mRNA vaccines
Cases of mild myocarditis are being reported in people who have been vaccinated with the COVID-19 mRNA vaccines.
Myocarditis is an inflammation of the heart...
12-week gap for second Pfizer vaccine achieves peak antibody resistance
Delaying the second Pfizer vaccine dose to 12 weeks significantly increases antibody resistance in older people, a new study has found.
Researchers at the University...
COVID-19 pandemic marks a new era for global health policy
Leaders at the G20 summit committed to a series of actions aiming to accelerate the end of the COVID-19 pandemic across the globe, and...
Exploring vaccine storage and delivery
HEQ speaks with Thomas Sorensen, Senior Manager at UNICEF, about the cold chain and the challenges facing vaccine refrigeration.
Global charity UNICEF has been delivering...
Refrigeration and the vaccine cold chain
HEQ speaks with AREA President Marco Buoni about the role of refrigeration and the cold chain in combating the COVID-19 pandemic.
The cold chain is...
EU Vaccine Strategy: supporting COVID-19 therapeutics development
The European Commission will be complementing the EU Vaccines Strategy by supporting the development of COVID-19 therapeutics, including the treatment of long-COVID.
As part of...
Understanding ultra-low freezers with B Medical Systems
Ultra-low freezers, or ULTs, are special freezers built to reach extremely low temperatures. These products can easily reach a temperature of -86°C but can...
B Medical Systems and Kuehne+Nagel BeLux open new distribution centre
B Medical Systems, a Luxembourg based global leader of vaccine cold chain solutions and an established manufacturer and distributor of blood management and medical...
